Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for… (NCT07313748) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for the Elderly.
Italy3,000 participantsStarted 2025-11-01
Plain-language summary
The goal of this observational, point-prevalence study is to assess the burden of palliative care needs among adults hospitalised in Internal Medicine and Geriatrics wards, and among residents of long-term care facilities, on the National Palliative Care Day (11 November). The main question it aims to answer is: What is the prevalence of unmet palliative care needs in hospital and long-term care settings on 11 November? Participants (patients and residents) will be evaluated through a structured, web-based questionnaire designed for this study. The survey will collect clinical, functional, and symptom-related data- including comorbidities, mobility, nutritional status, dysphagia, pressure ulcers, indicators of palliative care needs (NECPAL), pain assessment, and delirium screening (4AT)-to produce a detailed snapshot of palliative care needs across settings.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years
* Admitted to participating Internal Medicine or Geriatrics wards or resident in participating long-term care facilities for older adults (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November (National Palliative Care Day)
* Able to provide: written informed consent for study participation and data processing, or oral consent supported by a relative/caregiver/legal proxy
Exclusion Criteria:
\- Inability to provide written informed consent and absence of a relative/caregiver/legal proxy able to support oral consent for participation and data processing
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.